Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 76, Issue 6, Pages 851-866
Publisher
Springer Science and Business Media LLC
Online
2020-03-15
DOI
10.1007/s00228-020-02854-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study
- (2019) Yan Xie et al. BMJ-British Medical Journal
- Deleterious effect of proton pump inhibitors on the disease course of cirrhosis
- (2019) Tamás Janka et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis
- (2019) P Laoveeravat et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
- (2019) Marianne Anastasia De Roza et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Adverse outcomes of long-term use of proton pump inhibitors
- (2018) Md.Mohaimenul Islam et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review
- (2018) Timothy P. Shiraev et al. Heart Lung and Circulation
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
- (2018) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
- Proton Pump Inhibitors: Review of Emerging Concerns
- (2018) Avinash K. Nehra et al. MAYO CLINIC PROCEEDINGS
- Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding
- (2018) Tsung-Hsing Hung et al. Clinics and Research in Hepatology and Gastroenterology
- Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel
- (2018) Riley Batchelor et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C
- (2018) Wei-Yu Kao et al. HEPATOLOGY
- Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome
- (2018) Amandeep Singh et al. NUTRITION IN CLINICAL PRACTICE
- Letter: proton pump inhibitors use and risk of hepatocellular carcinoma: A meta-analysis of observational studies
- (2018) Jian Zhao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma-authors’ reply
- (2018) Yu-Hsuan Joni Shao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics
- (2018) Silvia Nardelli et al. HEPATOLOGY
- Risk factors for developing liver cancer in people with and without liver disease
- (2018) Jae Kyung Suh et al. PLoS One
- PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-Analysis
- (2018) Alexandra Demcsák et al. Frontiers in Physiology
- Association between proton pump inhibitors and hepatic encephalopathy
- (2017) Jin Bian et al. MEDICINE
- The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis
- (2017) Surapon Nochaiwong et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus
- (2017) Cristina Llorente et al. Nature Communications
- Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies
- (2017) Yi Yang et al. Drug Design Development and Therapy
- Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans
- (2017) Yan Xie et al. BMJ Open
- The impact of proton pump inhibitor therapy on patients with liver disease
- (2016) H. L. Cole et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- National trends in prescription drug expenditures and projections for 2016
- (2016) G. T. Schumock et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Proton Pump Inhibitors Accelerate Endothelial SenescenceNovelty and Significance
- (2016) Gautham Yepuri et al. CIRCULATION RESEARCH
- Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis
- (2016) Ting Yu et al. DIGESTIVE AND LIVER DISEASE
- Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival
- (2015) Reidar Fossmark et al. APMIS
- Systematic Toxicity Mechanism Analysis of Proton Pump Inhibitors: An In Silico Study
- (2015) Dingfeng Wu et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
- (2015) Elizabeth D. Kantor et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis
- (2014) G. Dultz et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites
- (2014) Mattias Mandorfer et al. PLoS One
- Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
- (2013) Philip O Katz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Assessing compound carcinogenicityin vitrousing connectivity mapping
- (2013) Florian Caiment et al. CARCINOGENESIS
- Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity
- (2013) Soo Young Kim et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Inhibition of lysosomal enzyme activities by proton pump inhibitors
- (2013) Wensheng Liu et al. JOURNAL OF GASTROENTEROLOGY
- Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis
- (2013) Jee Hye Kwon et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Meta-analysis: effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel
- (2010) C. S. KWOK et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oncogenes and Tumor Suppressor Genes
- (2010) E. Y. H. P. Lee et al. Cold Spring Harbor Perspectives in Biology
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Tumor suppressor and hepatocellular carcinoma
- (2008) Juliette Martin WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now